Author

M. Kahan-Hanum

Observed name: M Kahan-Hanum

OpenAlex ID: A5065833702

126 A phase 1b/2a randomized, double-blind, placebo-controlled, multicenter study evaluating nebulized phage therapy in people with cystic fibrosis with chronic Pseudomonas aeruginosa pulmonary infection

2023 · U. Rappo, M. Kahan-Hanum, et al. · Journal of Cystic Fibrosis · 2

DOP072 Fecal host transcriptomics: a novel tool to monitor disease activity in patients with inflammatory bowel disease

2026 · A Segal, Y Weintraub, et al. · Journal of Crohn s and Colitis

P0205 Fecal host transcriptomics accurately assesses endoscopic inflammatory activity in patients with inflammatory bowel diseases

2025 · Y Weintraub, A Segal, et al. · Journal of Crohn s and Colitis

P095 A phase 1b/2a randomized, double-blind, placebo-controlled, multicentre study evaluating nebulized phage therapy in cystic fibrosis subjects with chronic Pseudomonas aeruginosa pulmonary infection

2023 · U. Rappo, M. Kahan-Hanum, et al. · Journal of Cystic Fibrosis

531 Developing nebulized phage therapy for chronic Pseudomonas aeruginosa pulmonary infections in people with cystic fibrosis

2022 · M. Kahan-Hanum, N. Buchshtab, et al. · Journal of Cystic Fibrosis

ePS3.06 Isolation and characterisation of nebulised phage for treatment of chronic Pseudomonas aeruginosa (Pa) pulmonary infections in cystic fibrosis (CF) patients

2022 · M. Kahan-Hanum, S. Kredo-Russo, et al. · Journal of Cystic Fibrosis

Works count: 6

Citation count: 2

H-index: 1

I10-index: